Traws Pharma, Inc. — Director's Dealing 2019

Apr 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2018-12-12

Reporting Person: Maniar Manoj (SVP - Product Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-12	Stock Option (right to purchase)	$3.41	A	5000	Acquired	2028-12-12	Common Stock (5000)	Direct

Footnotes

F1: These options vest 100% on the first anniversary of the grant date.